Boston

A STAT Investigation By Kathleen McLaughlin

HHS relaxed oversight of problematic Covid-19 tests despite being told of accuracy concerns

Biotech By Anissa Gardizy — Boston Globe

Foghorn Therapeutics raises $120 million in IPO

Biotech By Jonathan Saltzman — Boston Globe

Disarm Therapeutics bought by Lilly for $135 million

First Opinion By Kathryn Holroyd, Neha Limaye, and Hallie Rozansky

As the second surge looms, systems issues — not ‘weary staff’ — should be the focus for hospital safety

First Opinion By Pardis Sabeti and Yolanda Botti-Lodovico

A mumps epidemic has a lot to teach colleges about reopening safely in the time of coronavirus

Biotech By Jonathan Saltzman — Boston Globe

Biotech looking to fight kidney disease launches with $51 million

Health Tech By Rebecca Robbins, Erin Brodwin, and Casey Ross

The health tech tracker for the fourth quarter: 14 pivotal industry events to watch

Health Tech By Casey Ross

Teladoc’s tussle with Amwell raises questions about defining property rights in digital health

Health Tech By Rebecca Robbins

When AI is the opposite of sinister: An MIT researcher is held up as model of how algorithms can benefit humanity

Health Tech By Larry Edelman — Boston Globe

Amwell rides IPO wave with expanded stock sale

Biotech By Andrew Joseph

Patent board delivers blow to University of California over its CRISPR invention claims

Biotech By Jonathan Saltzman — Boston Globe

Casma Therapeutics brings in another $50 million to target muscular dystrophy

Biotech By Jonathan Saltzman — Boston Globe

Korro Bio raises $90 million to fix mutations that cause diseases

Something Ventured By Kate Sheridan

Oncorus and three other startups got venture funding a year ago. Did it help them do what they said it would?

Health Tech By Andy Rosen — Boston Globe

Biofourmis raises $100 million for remote patient monitoring tools

Health By Elizabeth Cooney

Immigration status, housing, and food-service work explain Covid-19’s burden on Latinos

Biotech By Elizabeth Cooney

Foundation Medicine wins FDA approval for liquid biopsy able to detect mutations in multiple cancers 

In the Lab By Pratibha Gopalakrishna

Scientists create a synthetic lining for the intestine to make delivering drugs easier

Health Tech By Larry Edelman — Boston Globe

Telehealth company Amwell files to sell shares to public, Google

Health By Jonathan Saltzman — Boston Globe

Biogen conference likely led to 20,000 Covid-19 cases in Boston area, researchers say

Pharma By Adam Feuerstein

J&J to buy Momenta Pharma in a bid to bolster autoimmune disease pipeline

Health By Jonathan Saltzman — Boston Globe

‘We’re going to keep going’: A new clinical trial for ALS gives patients hope

Biotech By Kate Sheridan

4 questions for neurology startups as venture investors pour millions into the field

Biotech By Jonathan Saltzman — Boston Globe

Hospital president wrote opinion piece critical of drug pricing efforts, but didn’t disclose role on Moderna board

Biotech By Adam Feuerstein

The FDA accepted Biogen’s Alzheimer’s drug submission. Next up, a highly anticipated outside expert review